Nexiguran ziclumeran reduces serum TTR levels in transthyretin amyloid cardiomyopathy
1. In this phase one clinical trial, among patients with transthyretin amyloid cardiomyopathy (ATTR-CM), it was found that nexiguran ziclumeran ...
Tag: transthyretin amyloid cardiomyopathy
Acoramidis slows disease progression in transthyretin amyloid cardiomyopathy
1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy exposed to acoramidis had slower disease progression than ...
Simple score developed to predict increased risk of transthyretin amyloid cardiomyopathy in patients with heart failure with preserved ejection fraction
1. The simple score comprised of 3 clinical (age, male sex, hypertension diagnosis) and 3 echocardiographic (ejection faction, posterior wall ...